Factor V Leiden, prothrombin G20210A and antibodies against phospholipids in recurrent spontaneous abortion [5]

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 8, 2004, Pages 1482-1484

  Mtiraoui, N ^a   Borgi, L ^a   Gris, J C ^b   Almawi, W Y ^c   Mahjoub, T ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b UNIV MONTPELLIER   (France)

^c ARABIAN GULF UNIVERSITY   (Bahrain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTHROMBIN;

ADULT; ARTICLE; CONTROLLED STUDY; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC RISK; GENETIC SCREENING; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SPONTANEOUS ABORTION; STATISTICAL SIGNIFICANCE; TUNISIA;

ABORTION, HABITUAL; ADULT; ANTIBODIES; ANTIBODIES, ANTIPHOSPHOLIPID; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR V; FEMALE; GENOTYPE; HUMANS; PHOSPHOLIPIDS; POINT MUTATION; PREGNANCY; PROTHROMBIN;

EID: 13244289809     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00856.x     Document Type: Article

References (18)

1. Martinelli I, Bucciarelli P, Margaglione M, De Stefano V, Castaman G, Mannucci PM. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both. Br J Haematol 2000; 111: 1223-9.
2. Branch DW. Antiphospholipid antibodies and reproductive outcome: the current state of affairs. J Reprod Immunol 1998; 38 75-87.
3. Lockshin MD, Druzin ML, Goei S, Qamar T, Magid MS, Jovanovic L. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Engl J Med 1985; 313: 152-6.
4. Galli M. Which antiphospholipid antibodies should be measured in the antiphospholipid syndrome? Haemostasis 2000; 30: 57-62.
5. Parke AL, Wilson D, Maier D. The prevalence of antiphospholipid antibodies in women with recurrent spontaneous abortion, women with successful pregnancies, and women who have never been pregnant. Arthritis Rheum 1991; 34: 1231-5.
6. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Driven RJ, De Ronde H, Van Der Veden PA, Reitsma Ph. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
7. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
8. Howard C, Ophira S, Daniel S, Rim D, Nurith R, Aida I. Prevalence of genetic markers for thrombophilia in recurrent pregnancy loss. Human Reprod 2002; 6: 1633-7.
9. Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY. Prevalence of factor V G1691A and prothrombin G20210A gene mutations in a recurrent miscarriage population. Am J Hematol 2002; 71: 300-5.
10. Pauer HU, Voigt-Tschirschwitz T, Hinney B, Burfeind P, Wolf C, Emons G, Neesen J. Analyses of three common thrombophilic gene mutations in German women with recurrent abortions. Acta Obstet Gynecol Scand 2003; 82: 942-7.
11. Espana F, Villa P, Mira Y, Grancha S, Royo M, Estelles A, Vaya A, Aznar J. Factor V Leiden and antibodies against phospholipids and protein S in a young woman with recurrent thromboses and abortion. Haematologica 1999; 84: 80-4.
12. Dizon-Townson DS, Kinney S, Branch DW, Ward K. The factor V Leiden mutation is not a common cause of recurrent miscarriage. J Reprod Immunol 1997; 34: 217-23.
13. Wramsby ML, Sten-Linder M, Bremme K. Primary habitual abortions are associated with high frequency of factor V Leiden mutation. Fertil Steril 2000; 74: 987-91.
14. Alfirevic Z, Mousa HA, Martlew V. Briscoel, Perezcasol M, Toh CH. Postnatal screening for thrombophilia in women with severe pregnancy complications. Obstet Gynecol 2001; 97: 753-9.
15. Sarig G, Younis JS, Hoffman R, Lanir N, Blumenfeld Z, Brenner B. Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage. Fertil Steril 2002; 77 342-7.
16. Mercier E, Quere I, Mares P, Gris JC. Primary recurrent miscarriages: anti-beta2-glycoprotein I IgG antibodies induce an acquired activated protein C resistance that can be detected by the modified activated protein C resistance test. Blood 1998; 92: 2993-4.
17. Chafa O, Reghis A, Aubert A, Fischer AM. Prevalence of the FVQ506 (factor V Leiden) mutation in the normal and thrombophilic Algerian population. Br J Haematol 1997; 97: 688-9.
18. Mathonnet F, Nadifi S, Serazin-Leroy V, Dakouane M, Giudicelli Y. Absence of factor V Leiden mutation and low prothrombin G 20210 A mutation prevalence in a healthy Moroccan population. Thromb Haemost 2002; 88: 1073-4.